Cardiovascular and Vein Center of Florida — Bradenton, Florida

Cardiovascular and Vein Center of Florida is a clinical research site located in Bradenton, Florida, United States 34209.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Cardiovascular and Vein Center of Florida has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity.

Sponsors: Amgen, Boston Scientific Corporation, Bayer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bradenton

Browse all research sites in Florida · View every site in Bradenton

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cardiovascular and Vein Center of Florida?

Cardiovascular and Vein Center of Florida has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cardiovascular and Vein Center of Florida conducted?

Cardiovascular and Vein Center of Florida has 5 clinical trials on record, with 3 currently active. Their work covers Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity.

Is Cardiovascular and Vein Center of Florida accredited by Crixeo Clinical Trials?

Cardiovascular and Vein Center of Florida has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cardiovascular and Vein Center of Florida?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.